Tower Research Capital LLC (TRC) - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 48 filers reported holding INMUNE BIO INC in Q4 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INMUNE BIO INC
ValueSharesWeighting
Q1 2024$26,496
+53.4%
2,255
+47.0%
0.00%
Q4 2023$17,273
+0.3%
1,534
-39.7%
0.00%
-100.0%
Q3 2023$17,217
+20.8%
2,543
+62.0%
0.00%
Q2 2023$14,256
+109561.5%
1,570
-22.9%
0.00%
Q1 2023$13
+30.0%
2,037
+35.5%
0.00%
Q4 2022$10
-100.0%
1,503
-61.6%
0.00%
Q3 2022$25,000
-66.7%
3,909
-46.5%
0.00%
-100.0%
Q4 2021$75,000
+200.0%
7,306
+421.5%
0.00%0.0%
Q2 2021$25,000
-84.3%
1,401
-89.5%
0.00%
-66.7%
Q1 2021$159,000
+2550.0%
13,365
+2127.5%
0.00%
Q3 2020$6,000
-14.3%
600
-55.7%
0.00%
Q2 2020$7,000
+600.0%
1,355
+564.2%
0.00%
Q3 2019$1,0002040.00%
Other shareholders
INMUNE BIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
Financial Advocates Investment Management 224,667$1,303,0000.14%
Retirement Group, LLC 700$4,0000.00%
TRUE Private Wealth Advisors 1,000$5,0000.00%
Advisor Group, Inc. 200$1,0000.00%
Covington Capital Management 1,000$6,0000.00%
BlackRock Inc. 6,552$38,0000.00%
DEUTSCHE BANK AG\ 46,048$267,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 100$1,0000.00%
Advisory Services Network, LLC 500$3,0000.00%
BANK OF AMERICA CORP /DE/ 1,703$10,0000.00%
View complete list of INMUNE BIO INC shareholders